Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab

NCT05184179 · clinicaltrials.gov ↗

COMPLETED

Status

5450

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Dyslipidemia

Interventions

DRUG: Olmesartan Medoxomil

Sponsor

Daewoong Pharmaceutical Co. LTD.